IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study is a research paper published in Brain Behavior and Immunity (2024). On theSindex it has a DataRank of 0.291. It has been cited 5 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0227
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
NIAAA NIH HHS
Grant: P20 AA017830
NIDA NIH HHS
Grant: R01 DA057928
NIAAA NIH HHS
Grant: K01 AA028050
NIAAA NIH HHS
Grant: R01 AA027486
National Institutes of Health
Grant: 1P20AA017830-01
The Mayo Clinic Center for Individualized Treatment of Alcohol Dependence
National Institutes of Health
Grant: 1R01AA027486-01
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics
National Institutes of Health
Grant: 5K01AA028050-05
Acamprosate pharmacogenomics: iPSC based model of alcohol use disorder
National Institutes of Health
Grant: 5R01DA057928-03
Single cell multi-omics of iPSC-derived brain organoids from patients with opioid use disorder: synthetic opioids as molecular probes
Fields of Study
MeSH Terms
Keywords